Search Results
Search results for "medicinal chemistry"
Results found for "medicinal chemistry"
- Adenosine receptor signalling in Alzheimer's disease
Although there are no available medicines targeting these receptors approved for treating dementia, we
- The Truth About GPCR Product Launches: Years in the Making
It started not with biologyâbut with chemistry. Revvity and academic collaborator Prof. Mini Timeline: The Road to pHSense â Initial lanthanide probe design with Durham University (chemistry Revnityâs partnership with Durham (chemistry) and the Institute of Functional Genomics in Montpellier
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Precision Medicine Finally, DMS aids in the advent of precision medicine by enabling a more detailed
- Exscientia is 10 years old this July!
the first-ever AI-designed drug candidates to enter clinical trials, the first AI-driven precision medicine
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
"Despite the importance of members of the GPCR superfamily as targets of a broad range of effective medicines
- đ° GPCR Weekly News, September 4 to 10, 2023
GPCR, was featured as Superluminal Medicines Launches to Drug Protein Conformations in a Flash. addiction treatment maker Indivior to make digital therapeutics for substance use disorders Superluminal Medicines
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
activation of G protein-coupled receptors (GPCRs) is of paramount importance to the field of cardiovascular medicine
- Orthosteric vs Allosteric Interactionsâ and the pHSense Shift in Internalization
Years of chemistry, photophysics, and pharmacology condensed into one breakthrough: pHSense , a reagent Rare-earth europium complexes offered potentialâbut the chemistry was brutal. They translated a fundamental principle of chemistry into a usable platform for pharmacologyâshowing how persistence, precision, and the courage to take on âimpossibleâ chemistry can shift the entire GPCR
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
His tools exist because he constantly asks: What limitation is chemistry solving here? Throughout his own journeyâfrom organic chemistry to chemical biology to GPCR imagingâevery pivotal step
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
focused on expanding its GPCR-focused structure-based drug design platform and enhancing translational medicine
- Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...
clinical development â Ghent, Belgium â March 10, 2022 â Confo Therapeutics, a leader in the discovery of medicines
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
the treatment of depression "Kaixinsan powder (KXS), a classic prescription of traditional Chinese Medicine
- Trevena Announce Submission of New Drug Application in China for OLINVYKÂź by its Partner Jiangsu ...
Jan. 27, 2022 A biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Chinaâs National Medical
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
MQ1-K39A represents the first step in the improvement of the MQ1 design from a medicinal perspective.
- Do You Believe AI Could Accelerate Drug Discovery?
innovation in automated screening and large-scale data analysis, paving the way for a new era in precision medicine and medical research.
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Discovery track will deliver breakthroughs, bold ideas, and the strategies shaping the next wave of medicines
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
journey from academic pharmacologist to biotech entrepreneurâbridging curiosity, AI/ML, and translational medicine
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
Ranking Partial Agonists Without Losing Meaning Chemists want a single number. These GPCR pharmacology insights are essential for directing chemistry toward the property that actually
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Premium: Sneak Peek Industry insights: Â Strategic biotech alliances (Chemspace/Enamine, Superluminal Medicines
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
However, the receptors that these medicines target have been described as the âlow-hangingâ fruit, and .0404802101 · Initial work on precision engineering of a small protein GPCR ligand using new peptide chemistry engineering small protein GPCR ligands Paolini-Bertrand, M. et al. (2018) The Journal of Biological Chemistry efficacy in a highly stringent model of HIV transmission Steinbach, K. et al. (2019) Science Translational Medicine
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
Their proprietary chemistry platform enables rapid generation of conjugates, such as labeled ligands,
- đ° GPCR Weekly News, July 10 to 16, 2023
News Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
cell function Protein Biochemist/Structural Biologist Senior Scientist/Staff Scientist, Computational Chemistry
- Amylin Receptor Signaling: Three Receptors From One, and How to Profile Each
The throughline The lesson running through this generation of metabolic medicines is that signaling quality
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
2024 Industry News Nxera Pharma appoints experienced commercial R&D executive Makoto Sugita as Chief Medical expanding GPCR landscape The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry cell function Protein Biochemist/Structural Biologist Senior Scientist/Staff Scientist, Computational Chemistry
- đ° GPCR Weekly News, May 1 to 7, 2023
Crinetics Pharmaceuticals First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags âAs Precision Medicine July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs Vice President, Medical
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⊿ Oct 28 - Nov 3, 2024
Meeting in 2025 NEW April 3 - 6, 2025 | ASPET 2025 NEW Â April 14 - 17, 2025 | 20th Drug Discovery Chemistry cell function Protein Biochemist/Structural Biologist Senior Scientist/Staff Scientist, Computational Chemistry
- đ° GPCR Weekly News, June 5 to 11, 2023
Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Jobs NEW Scientist I / Scientist II DOE (Native Mass Spectrometry) Senior Vice President of Global Medical
















